During the past few years, many experts have suggested that bipolar disorder — a serious illness resulting in significant psychosocial morbidity and excess mortality — is under-recognized, particularly in patients with major depression. Even patients who are diagnosed with bipolar disorder often wait more than 10 years after initially seeking treatment for the correct diagnosis to be made.
The clinical implications of the failure to recognize bipolar disorder in depressed patients include the under-prescription of mood-stabilizing medications, and an increased risk of rapid “cycling” — swings between manic and depressive phases. But, perhaps as a consequence of concerted efforts to improve the recognition of bipolar disorder, during the past few years we have observed the emergence of an opposite phenomenon — overdiagnosis.
In my own practice, my colleagues and I have encountered patients who reported that they were previously diagnosed with bipolar disorder, despite lacking a history of manic or hypomanic episodes. To be sure, we have also seen patients seeking treatment for depression who really did have bipolar disorder. However, there seemed to be more overdiagnosis than underdiagnosis.
We therefore conducted a study to examine empirically how often bipolar disorder might be over- and under-diagnosed. Seven hundred psychiatric outpatients were interviewed with the Structured Clinical Interview for DSM-IV (SCID) and completed a self-administered questionnaire that asked whether they had been previously diagnosed by a health-care professional with bipolar or manic-depressive disorder. Family history information was obtained from the patient regarding their immediate relatives.
Slightly more than 20 percent (145 patients) in our sample reported that they had been previously diagnosed as having bipolar disorder, significantly higher than the 12.9 percent rate based on the SCID. Less than half of those who reported that they had been previously diagnosed with bipolar disorder were diagnosed with bipolar disorder based on the SCID. Patients with SCID-diagnosed bipolar disorder had a significantly higher risk of bipolar disorder in their immediate family members than patients who self-reported a previous diagnosis of bipolar disorder that was not confirmed by the SCID. Patients who self-reported a previous diagnosis of bipolar disorder that was not confirmed by the SCID did not have a significantly higher risk for bipolar disorder than the patients who were negative for bipolar disorder by self-report and the SCID. Our findings, validated by family history, thus suggest that bipolar disorder was overdiagnosed.
Any study seeking to determine whether a psychiatric disorder is over-diagnosed will find that some patients with the condition do not have it upon re-interview. Such is the nature of the imperfect reliability of psychiatric diagnosis. The question, then, is not whether some patients previously given a diagnosis do not seem to have it upon re-interview, but rather how many . How high the percentage should be before claiming over-diagnosis is a significant problem and a value judgment. But we think that an over-diagnosis rate of more than 50 percent crosses the clinical significance threshold.
Over-diagnosis of bipolar disorder has costs. Mood stabilizers are the treatment of choice, and, depending on the medication, they can produce potentially significant health complications affecting renal, endocrine, hepatic, immunologic, or metabolic function.
The impact of marketing efforts by pharmaceutical companies and publicity probably plays a role in the emerging tendency to over-diagnose bipolar disorder. Direct-to-consumer advertisements that refer individuals to screening questionnaires can result in patients suggesting to their doctors that they have bipolar disorder. We have seen evidence of this in our practice. This does not necessarily reflect a problem with the performance of a screening questionnaire, but rather how these scales are used. Screening questionnaires maximize sensitivity, at a cost of false positives, because it is presumed that they are followed by expert clinical evaluation. But insufficient diagnostic rigor can result in overdiagnosis.
Clinicians are inclined to diagnose disorders that they feel more comfortable treating. We believe that the increased availability of medications that have been approved for the treatment of bipolar disorder might be influencing clinicians who are unsure whether or not a patient has bipolar disorder or borderline personality disorder to err on the side of diagnosing the disorder that is responsive to medication.
This bias is reinforced by the marketing of pharmaceutical companies to physicians, which has emphasized research on delayed diagnosis and under-recognition of bipolar disorder, possibly sensitizing clinicians accordingly. The campaign against under-recognition has probably resulted in some anxious, agitated and/or irritable depressed patients who complain of insomnia and “racing thoughts” being misdiagnosed with bipolar disorder.
The results of our study are consistent with prior studies suggesting possible problems with the diagnosis of bipolar disorder. With the greater number of medications approved for the treatment of bipolar disorder, along with multiple reports cautioning clinicians against underdiagnosis, it appears that overdiagnosis has become a greater problem than underdiagnosis. Both can have negative consequences.
Mark Zimmerman is associate professor of psychiatry and human behavior at Brown Medical School.
COPYRIGHT: PROJECT SYNDICATE
Unless Hollywood movies like Greenland, Deep Impact, and Armageddon have predictive powers and a rogue space rock is heading our way, stopping Chinese Communist Party expansionism is likely to prove the single most challenging and dangerous problem of our lifetimes. How can the United States, Taiwan, and other liberal democracies prepare for and prevent attacks from China? How can Washington bolster Taipei’s confidence when it doesn’t recognize Taiwan as a real country and, so far, lacks the political will to make major adjustments to its ossified China policy and Taiwan policy? How can Taiwan make itself heard on the world stage when
Hypersonic weapons are defined as armaments capable of traveling at speeds faster than Mach 5 and can be broadly classified into two types: hypersonic glide vehicles (HGV) and hypersonic cruise missiles. The former are launched into the upper atmosphere by ballistic missiles. The vehicle is then separated from the booster to maneuver, or glide, toward its target. The latter can be launched from a jet plane or rocket to reach supersonic speed before igniting a scramjet engine to achieve hypersonic speeds. As the US engages in a great-power competition with China and Russia, all three countries are racing to field hypersonic
The number of people emigrating from Hong Kong has been rapidly increasing, Hong Kong Census and Statistics Department data show, with the territory’s population dropping by 110,000 people from 2019 to this year. China’s imposition of a National Security Law has clearly triggered a massive population outflow. However, not only people but also foreign businesses are leaving Hong Kong. For example, Vanguard Group, the world’s second-largest asset management company, VF Corp and Sony Interactive Entertainment have moved their top regional management from Hong Kong to Singapore. LVMH Moet Hennessy Louis Vuitton, the world’s largest luxury goods company, has also relocated staff
Double Ten Day, Oct. 10 every year, is an important day for Taiwan, as it marks the Republic of China’s (ROC) National Day. Major holidays are usually a time for celebration and commemorative activities, but among all the clamor and excitement, Double Ten reflects one essential fact: that Taiwan is still not a normalized society. As usual, there was a large parade in front of the Presidential Office Building, displaying to the world Taiwan’s social diversity and its soft and hard power, and President Tsai Ing-wen (蔡英文) gave an address, relaying her message to the nation and to the world, while the
RSS